Cameron-Pimblett Antoinette, La Rosa Clementina, Davies Melanie C, Suntharalingham Jenifer P, Ishida Miho, Achermann John C, Conway Gerard S
Reproductive Medicine Unit, University College London Hospital, London, WC1N 6HU, UK.
Genetics & Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, WC1N 1EH, UK.
J Clin Endocrinol Metab. 2025 Apr 22;110(5):1279-1286. doi: 10.1210/clinem/dgae357.
Diabetes mellitus (DM) risk factors in Turner syndrome (TS) may include autoimmunity, obesity, β-cell dysfunction, genetic predisposition, and insulin resistance (IR).
This work aimed to evaluate glucose tolerance and DM risk factors in adults with TS.
A single-center study with 2 phases was conducted to determine the prevalence of DM and to assess DM risk markers comparing women with TS with and without impaired glucose tolerance (IGT). The study took place at a tertiary referral center, University College Hospitals. A total of 106 women with TS (age range, 18-70 years) undergoing annual health surveillance underwent oral glucose tolerance tests (OGTTs), with additional samples for autoimmunity and genetic analysis. Main outcome measures included glucose tolerance, insulin, autoimmune, and single-nucleotide variation (SNV) profile.
OGTT screening showed that among those without a previous DM diagnosis, 72.7% had normal glucose tolerance, 19.5% had IGT, and 7.6% were newly diagnosed with DM. OGTT identified more cases of DM than glycated hemoglobin A1c sampling alone. Women with IGT or DM were older, with higher body mass index and IR. No association was found between autoimmune markers glutamic acid decarboxylase (GAD), islet antigen-2, and zinc transporter 8, risk karyotypes, or selected SNVs and DM. In DM cases, GAD positivity was associated with requirement for insulin therapy. The median age of onset of the diagnosis of DM was 36 years (range, 11-56 years).
In the spectrum of DM subtypes, TS-associated DM lies between type 1 and type 2 DM with features of both. Key factors include weight and IR. Assessing C-peptide or GAD antibodies may aid future insulin requirement.
特纳综合征(TS)中的糖尿病(DM)风险因素可能包括自身免疫、肥胖、β细胞功能障碍、遗传易感性和胰岛素抵抗(IR)。
本研究旨在评估成年TS患者的糖耐量及DM风险因素。
开展了一项分为两个阶段的单中心研究,以确定DM的患病率,并通过比较有和没有糖耐量受损(IGT)的TS女性来评估DM风险标志物。该研究在三级转诊中心大学学院医院进行。共有106名年龄在18至70岁之间、接受年度健康监测的TS女性接受了口服葡萄糖耐量试验(OGTT),并采集了额外的样本用于自身免疫和基因分析。主要观察指标包括糖耐量、胰岛素、自身免疫和单核苷酸变异(SNV)谱。
OGTT筛查显示,在既往未诊断为DM的患者中,72.7%糖耐量正常;19.5%有IGT;7.6%为新诊断的DM。OGTT比单独检测糖化血红蛋白A1c能发现更多DM病例。患有IGT或DM的女性年龄更大,体重指数和IR更高。自身免疫标志物谷氨酸脱羧酶(GAD)、胰岛抗原2和锌转运体8、风险核型或选定的SNV与DM之间未发现关联。在DM病例中,GAD阳性与胰岛素治疗需求相关。DM诊断的中位发病年龄为36岁(范围11至56岁)。
在DM亚型范围内,TS相关的DM介于1型和2型DM之间,兼具两者特征。关键因素包括体重和IR。评估C肽或GAD抗体可能有助于预测未来的胰岛素需求。